Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,567.20
(
1.22%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
98.25
(
1.51%
)
Bitcoin
70,650.00
(
-0.35%
)
News Focus
News Focus
Post# of 257272
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: T Bishop post# 635

Wednesday, 12/17/2003 9:55:12 PM

Wednesday, December 17, 2003 9:55:12 PM

Post# of 257272
>>
Test 2:
Squalamine (13/39) vs. Macugen (Phase II – 54/900), Hypothesized Difference = -0.125
<<

I assume that’s a typo and you actually input the correct 6/24 figure for the Macugen phase-2 data as detailed in your narrative (rather than the 54/900 phase-3 figure as shown above). The test result looks OK so a typo is the only explanation that makes sense.

Once again, thanks for sharing your work. Did you notice that Biowatch asked what grade you received? I’d like to know too. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today